Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 24, 2014, 108 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $3.42 to $10,356,964.00.

Highlighted Stocks Traded by Insiders:

Old Line (OLBK) - FREE Research Report

Dent James F, who is Director at Old Line, bought 1,200 shares at $9.82 on Nov. 24, 2014. Following this transaction, the Director owned 65,600 shares meaning that the stake was boosted by 1.86% with the 1,200-share transaction.

The shares most recently traded at $15.92, up $6.10, or 38.29% since the insider transaction. Historical insider transactions for Old Line go as follows:

  • 4-Week # shares bought: 720
  • 4-Week # shares sold: 720
  • 12-Week # shares bought: 1,970
  • 12-Week # shares sold: 720
  • 24-Week # shares bought: 9,795
  • 24-Week # shares sold: 720

The average volume for Old Line has been 17,800 shares per day over the past 30 days. Old Line has a market cap of $169.6 million and is part of the financial sector and banking industry. Shares are up 10.28% year-to-date as of the close of trading on Monday.

Old Line Bancshares, Inc. operates as the bank holding company for Old Line Bank that provides commercial banking products and services to small and medium size businesses, entrepreneurs, professionals, consumers, and high net worth clients in Maryland. The stock currently has a dividend yield of 1.27%. The company has a P/E ratio of 16.6. Currently, there is 1 analyst who rates Old Line a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on OLBK - FREE

TheStreet Quant Ratings rates Old Line as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Old Line Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Computer (CSC) - FREE Research Report

Lawrie John M, who is President and CEO at Computer, sold 4,000 shares at $62.59 on Nov. 24, 2014. Following this transaction, the President and CEO owned 189,150 shares meaning that the stake was reduced by 2.07% with the 4,000-share transaction.

The shares most recently traded at $63.05, up $0.46, or 0.73% since the insider transaction. Historical insider transactions for Computer go as follows:

  • 4-Week # shares sold: 20,000
  • 12-Week # shares sold: 20,000
  • 24-Week # shares sold: 42,527

The average volume for Computer has been 1.3 million shares per day over the past 30 days. Computer has a market cap of $8.8 billion and is part of the technology sector and computer software & services industry. Shares are up 13.55% year-to-date as of the close of trading on Monday.

Computer Sciences Corporation provides information technology (IT) and professional services and solutions in North America, Europe, Asia, and Australia. The company operates through Global Business Services, Global Infrastructure Services, and North American Public Sector segments. The stock currently has a dividend yield of 1.47%. The company has a P/E ratio of 14.9. Currently, there are 2 analysts who rate Computer a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSC - FREE

TheStreet Quant Ratings rates Computer as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Computer Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lannett (LCI) - FREE Research Report

Maher James M., who is Director at Lannett, bought 500 shares at $45.08 on Nov. 24, 2014. Following this transaction, the Director owned 11,000 shares meaning that the stake was boosted by 4.76% with the 500-share transaction.

The shares most recently traded at $48.37, up $3.29, or 6.8% since the insider transaction. Historical insider transactions for Lannett go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 47,500
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 81,000

The average volume for Lannett has been 805,900 shares per day over the past 30 days. Lannett has a market cap of $1.6 billion and is part of the health care sector and drugs industry. Shares are up 46.31% year-to-date as of the close of trading on Monday.

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of branded pharmaceutical products in the United States. It offers solid oral, extended release, topical, and oral solution finished dosage forms of drugs that address a range of therapeutic areas. The company has a P/E ratio of 16.5. Currently, there are 3 analysts who rate Lannett a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on LCI - FREE

TheStreet Quant Ratings rates Lannett as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Lannett Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null